"Our study suggests that identification of neuropsychiatric symptoms, such as depression, anxiety, agitation or delusions, could be crucial to distinguish MCI patients with risk of faster cognitive ...

Mild cognitive impairment (MCI) is a slight decrease in a patient's cognitive function compared to a higher premorbid level. Symptoms remain objectively invisible, but the patients themselves complain ...

Results of a long-term, federally funded study of cognitively healthy adults -- most with a family history of Alzheimer's disease -- have added to evidence that low spinal fluid levels of a protein ...

A new study led by researchers at UC San Diego shows a certain protein detected in the blood can provide decades of early ...

Mild cognitive impairment is characterised by a decline in cognitive function that represents a transitional condition between the cognitive changes associated with normal ageing and those associated ...

Mild cognitive impairment—lapses such as missing appointments, losing things, and having trouble finding the words to describe something—affects millions of older adults across the United States. Yet ...

The risk for future incident mild cognitive impairment or dementia in older women was elevated with higher levels of plasma phosphorylated tau 217, according to data published in JAMA Network Open.“Ou ...

Dr. Petersen answers the question: 'Cognitive Impairment And Dementia Risk? May 4, 2009 -- Question: If I have mild cognitive impairment, does that mean I'm going to develop dementia or Alzheimer's ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Soeren Mattke receives funding from Alzheon, Biogen, C2N, Eisai, Lilly and Roche/Genentech through the University of Southern California. He consults to Biogen, C2N, Eisai, Novartis, Novo Nordisk and ...